Non-small cell lung cancerRadiotherapyConformal radiotherapyTarget splittingDose escalationTo investigate therapeutic outcome of dose escalation 鈮 80 Gy in nonresected non-small cell lung cancer (NSCLC).#124 consecutive patients with histologically/cytologically proven NSCLC were enrolled. Tumor stage I,...
Dave shares his stage 1B non-small cell lung cancer diagnosis, a neuroendocrine tumor, and how he got through a lobectomy (surgery) and months-long recovery. In his story, Dave also highlights his advocacy work and gives guidance to other lung cancer patients and caregivers on how to ...
[Non-small cell bronchogenic can- cer in stage IA: mortality patterns after surgery]. Arch Bronconeumol 2005;41:180-184.Padilla J, Penalver JC, Jorda C, Calvo V, Escriva J, Ceron J, Garcia Zarza A, Pastor J, Blasco E. [Non-small cell bronchogenic cancer in stage IA: mortality ...
Surgical treatment of the non-small cell lung cancer: Stage I (T1N0-T2N0) and stage II (T1N1-T2N1). Prognostic factors, results and recurrence - Lung Cancerdoi:10.1016/0169-5002(94)92245-4NoneLung Cancer
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. 20, 494–503 (2019). Article PubMed Google Scholar ...
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.What are the subtypes of NSCLC?Squamous cell carcinoma is found in cells that line the airways of the lungs. It is usually found in the middle of the lung. Adenocarcinoma is found in cells that produce mucus. It...
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni
To determine the causes of death in patients operated on for stage IB non-small cell lung cancer (NSCLC) and to assess the impact on survival of the number of lymph nodes removed. We studied 300 patients operated on for stage IB NSCLC. Only palpable or visible lymph nodes were excised. ...
wedge resection The optimal therapy for stage I non-small-cell lung cancer (NSCLC) is lobectomy for patients who are considered to be at risk [1] ... S Suppiah,P Linden,J Robke,... - 《Expert Review of Anticancer Therapy》 被引量: 1发表: 2012年 Wedge resection versus lobectomy for...
P: 1-2 Perioperative nivolumab results in favourable long-term outcomes in patients with locally advanced resectable non-small-cell lung cancer As one of the first studies testing perioperative anti-PD-(L)1 antibodies in resectable non-small-cell lung cancer (NSCLC), NADIM now confirms, in its...